Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma

European Journal of Cancer

Volumn 50, Issue 7, 2014, Pages 1259-1268

  Park, Do Hyun ^a   Lee, Sang Soo ^a   Park, So Eun ^a   Lee, Jae Lyun ^a   Choi, Jun Ho ^a   Choi, Hee Jung ^a   Jang, Ji Woong ^a   Kim, Hyoung Jung ^a   Eum, Jun Bum ^a   Seo, Dong Wan ^a   Lee, Sung Koo ^a   Kim, Myung Hwan ^a   Lee, Jung Bok ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Overall survival; Photodynamic therapy; Randomised trial; S 1

Indexed keywords

DOXIFLURIDINE; FLUOROPYRIMIDINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ABDOMINAL DISCOMFORT; ADULT; ANEMIA; ANOREXIA; ARTICLE; BILE DUCT CARCINOMA; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CHOLANGITIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; NAUSEA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

CHOLANGIOCARCINOMA; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; RANDOMISED TRIAL; S-1;

ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXONIC ACID; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; PYRIMIDINES; QUALITY OF LIFE; RETREATMENT; SURVIVAL ANALYSIS; TEGAFUR; UNITED STATES;

EID: 84897376319     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.01.008     Document Type: Article

References (32)

1. S.A. Khan, B.R. Davidson, R.D. Goldin, N. Heaton, J. Karani, and S.P. Pereira et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut 61 12 2012 1657 1669
2. M. Kahaleh, R. Mishra, V.M. Shami, P.G. Northup, C.L. Berg, and P. Bashlor et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy Clin Gastroenterol Hepatol 6 3 2008 290 297
3. A.A. Polydorou, S.R. Cairns, J.F. Dowsett, A.R. Hatfield, P.R. Salmon, and P.B. Cotton et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion Gut 32 6 1991 685 689
4. M. Ducreux, C. Liguory, J.F. Lefebvre, O. Ink, A. Choury, and J. Fritsch et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors Dig Dis Sci 37 5 1992 778 783
5. J. Deviere, M. Baize, J. de Toeuf, and M. Cremer Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage Gastrointest Endosc 34 2 1988 95 101
6. M.E. Ortner, K. Caca, F. Berr, J. Liebetruth, U. Mansmann, and D. Huster et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study Gastroenterology 125 5 2003 1355 1363
7. T. Zoepf, R. Jakobs, J.C. Arnold, D. Apel, and J.F. Riemann Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy Am J Gastroenterol 100 11 2005 2426 2430
8. G.A. Prasad, K.K. Wang, T.H. Baron, N.S. Buttar, L.M. Wongkeesong, and L.R. Roberts et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma Clin Gastroenterol Hepatol 5 6 2007 743 748
9. G.J. Gores A spotlight on cholangiocarcinoma Gastroenterology 125 5 2003 1536 1538
10. J. Valle, H. Wasan, D.H. Palmer, D. Cunningham, A. Anthoney, and A. Maraveyas et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 14 2010 1273 1281
11. M.A. Ortner Photodynamic therapy for cholangiocarcinoma: overview and new developments Curr Opin Gastroenterol 25 5 2009 472 476
12. J.P. Talreja, M. Degaetani, K. Ellen, T. Schmitt, M. Gaidhane, and M. Kahaleh Photodynamic therapy in unresectable cholangiocarcinoma: not for the uncommitted Clin Endosc 46 4 2013 390 394
13. H. Ueno, T. Okusaka, M. Ikeda, Y. Takezako, and C. Morizane Phase II study of S-1 in patients with advanced biliary tract cancer Br J Cancer 91 10 2004 1769 1774
14. H. Ueno, T. Ioka, M. Ikeda, S. Ohkawa, H. Yanagimoto, and N. Boku et al. Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study J Clin Oncol 31 13 2013 1640 1648
15. K. Tatsumi, M. Fukushima, T. Shirasaka, and S. Fujii Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts Jpn J Cancer Res 78 7 1987 748 755
16. T. Shirasaka, Y. Shimamoto, and M. Fukushima Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats Cancer Res 53 17 1993 4004 4009
17. I. Park, J.L. Lee, M.H. Ryu, T.W. Kim, H.M. Chang, and S.S. Lee et al. Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patients Oncology 76 2 2009 126 132
18. W.R. Jarnagin, Y. Fong, R.P. DeMatteo, M. Gonen, E.C. Burke, and B.J. Bodniewicz et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 4 2001 507 517 discussion 517-9
19. do H. Park, J.E. Koo, J. Oh, Y.H. Lee, S.H. Moon, and S.S. Lee et al. EUS-guided biliary drainage with one-step placement of a fully covered metal stent for malignant biliary obstruction: a prospective feasibility study Am J Gastroenterol 104 9 2009 2168 2174
20. B.R. Weston, W.A. Ross, R.A. Wolff, D. Evans, J.E. Lee, and X. Wang et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112 11 2008 2417 2423
21. R.L.P.Y. Hebert, P.D. Mauldin, P.R. Tarnasky, L. Aanakken, W. Hennessey, and P.B. Cotton DDQ-15 health-related quality of life instrument for patients with digestive disorders Health Serv Outcomes Res Methodol 2 2001 137 156
22. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, and R. Ford et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2 2009 228 247
23. B.R. Blechacz, W. Sanchez, and G.J. Gores A conceptual proposal for staging ductal cholangiocarcinoma Curr Opin Gastroenterol 25 3 2009 238 239
24. F. Berr, M. Wiedmann, A. Tannapfel, U. Halm, K.R. Kohlhaw, and F. Schmidt et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 31 2 2000 291 298
25. Pereira S, Hughes SK, Roughton M, O'Donoghue P, Wasan HS, Valle J, et al. Photostent-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase III trial [abstract]. Presented the European Society for Medical Oncology (ESMO) 2010 congress, October 8-12, Milan, Italy; 2010. [Abstract 8020].
26. M. Kahaleh Photodynamic therapy in cholangiocarcinoma J Natl Compr Canc Netw 10 Suppl 2 2012 S44 S47
27. C.S. Shim, Y.K. Cheon, S.W. Cha, S. Bhandari, J.H. Moon, and Y.D. Cho et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment Endoscopy 37 5 2005 425 433
28. G.C. Harewood, T.H. Baron, A. Rumalla, K.K. Wang, G.J. Gores, and L.M. Stadheim et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma J Gastroenterol Hepatol 20 3 2005 415 420
29. F.L. Dumoulin, T. Gerhardt, S. Fuchs, C. Scheurlen, M. Neubrand, and G. Layer et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma Gastrointest Endosc 57 7 2003 860 867
30. Y.K. Cheon, T.Y. Lee, S.M. Lee, J.Y. Yoon, and C.S. Shim Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma HPB (Oxford) 14 3 2012 185 193
31. D.G. Haller, J. Cassidy, S.J. Clarke, D. Cunningham, E. Van Cutsem, and P.M. Hoff et al. Potential regional differences for the tolerability profiles of fluoropyrimidines J Clin Oncol 26 13 2008 2118 2123
32. B. Chuah, B.C. Goh, S.C. Lee, R. Soong, F. Lau, and M. Mulay et al. Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients Cancer Sci 102 2 2011 478 483